Teva Stands By Orange Book Listings As FTC Takes Further Action

Firm Responds To Reports Of FTC Investigation Over Inhaler Patents, After Refusal To Delist

 
• By Dave Wallace
  
Orange Book
Teva says its patents are properly listed in the FDA’s Orange Book • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin